Discounted Cash Flow

Staar Surgical Co.

STAA · Based on 10 years of SEC filings · Converted from JPY to USD

⚠ Cash flow predictability 31/100 (unstable) — FCF YoY std dev 83%, net income 75% (full history)

DCF estimate unavailable — only_6_profitable_out_of_10

Average annual growth rates

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income
Dividends

Average annual growth is the mean year-over-year change across each period.

Endpoint CAGR (better for long term trend)

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Endpoint CAGR is the compound annual rate from the first to last year in each period.

Projections use average year-over-year growth. Change this in Settings.

Projected growth rate

Free cash flow growth
10-year: — 5-year: — 3-year: —
Averaged growth (FCF & NI)
10-year: — 5-year: — 3-year: —
Net income growth
10-year: — 5-year: — 3-year: —
Sales growth (not added to calculations)
10-year: — 5-year: — 3-year: —

Click a greyed-out slider to switch metrics. Slide between the 10-year, 5-year, and 3-year historic growth rates for FCF, net income, or their average.

%
%

Historical inputs (10 fiscal years)

YEAR Sales Net Income Free Cash Flow Net Margin EPS (diluted)
2017 $588.1k $-13.9k $11.7k -2.4% $-0.05
2018 $148.4k (-74.8%) $32.2k (332.3%) $68.3k (482.3%) 21.7% (1020.1%) $0.12 (340.0%)
2019 $135.4k (-8.8%) $91.2k (182.8%) $101.9k (49.2%) 67.3% (210.0%) $0.32 (166.7%)
2020 $974.7k (619.9%) $91.2k (0.0%) $167.4k (64.3%) 9.4% (-86.1%) $0.32 (0.0%)
2021 $1.5m (53.5%) $159.0k (74.4%) $47.4k (-71.7%) 10.6% (13.7%) $0.52 (62.5%)
2022 $1.8m (23.4%) $251.5k (58.2%) $114.3k (141.0%) 13.6% (28.2%) $0.81 (55.8%)
2023 $2.1m (13.4%) $138.5k (-44.9%) $-23.3k (-120.4%) 6.6% (-51.4%) $0.44 (-45.7%)
2024 $2.0m (-2.6%) $-131.1k (-194.7%) $-49.8k (-113.4%) -6.4% (-197.2%) $-0.41 (-193.2%)
2025 $1.6m (-23.7%) $-522.1k (-298.1%) $-259.9k (-422.2%) -33.6% (-421.9%) $-1.62 (-295.1%)
2026 $1.6m (0.0%) $-522.1k (0.0%) $-222.2k (14.5%) -33.6% (0.0%) $-1.62 (0.0%)

Base FCF: (latest fiscal year)

Discount rate: %

Terminal growth:

Projection period: years

Alt A decline yrs:

Alt B total yrs:

SEC filings report in JPY. Values above are converted to USD for comparison with the US-listed share price.

Projected cash flows

Year Projected cash flow Discount Factor Present Value

PV of projected FCF:

Terminal FCF:

Terminal value:

PV of terminal value:

Enterprise value (DCF):

DCF price per share:

Current price:

Alternative DCF Models

Model Fair Value Upside PV(FCFs) PV(Terminal) Total Years
Standard (10yr→TV) 10 + TV
Alt A (Gradual Decline)
Alt B (30yr Hard Stop) N/A

This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.

+ 10YR Financials Balance Sheet (10YR) Cash Flow (10YR) DCF Model

only_6_profitable_out_of_10

Once the company meets all DCF eligibility criteria (sufficient history, profitability, growth trends), an estimate will become available automatically. No action is needed.